Gerresheimer: Difference between revisions
Artikel angelegt |
m PPArtikel hinzugefügt |
||
| (One intermediate revision by the same user not shown) | |||
| Line 38: | Line 38: | ||
Gerresheimer‘s plants in Europe, North America, South America and Asia generate revenues of approximately EUR 1.4 billion. | Gerresheimer‘s plants in Europe, North America, South America and Asia generate revenues of approximately EUR 1.4 billion. | ||
The product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, micro pumps, | The product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, micro pumps, pre-fillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry. | ||
| Line 44: | Line 44: | ||
'''Plastics & Devices'''<br> | '''Plastics & Devices'''<br> | ||
The product portfolio of this division includes customer-specific products for the simple and safe administration of medicines, such as insulin pens, inhalers and | The product portfolio of this division includes customer-specific products for the simple and safe administration of medicines, such as insulin pens, inhalers and pre-fillable syringes. | ||
In addtion it includes diagnostics and medical technology products such as lancets and test systems, as well as pharmaceutical plastic containers for liquid and solid medicines with closure and safety systems. | In addtion it includes diagnostics and medical technology products such as lancets and test systems, as well as pharmaceutical plastic containers for liquid and solid medicines with closure and safety systems. | ||
For the North American prescription retail market a complete line of regulatory compliant prescription containers for medication dispensing is available. | For the North American prescription retail market a complete line of regulatory compliant prescription containers for medication dispensing is available. | ||
| Line 75: | Line 75: | ||
* 1987 - Development of tubing-based pharmaceutical glass product business | * 1987 - Development of tubing-based pharmaceutical glass product business | ||
* 1991 - VIAG AG acquires a majority shareholding in Gerresheimer | * 1991 - VIAG AG acquires a majority shareholding in Gerresheimer | ||
* 1999 - Sale of the | * 1999 - Sale of the glass workse in Gerresheim | ||
* 1999 - Sale of 6 companies and strategic reorientation to focus on pharmaceutical, laboratory, cosmetic and small glass products | * 1999 - Sale of 6 companies and strategic reorientation to focus on pharmaceutical, laboratory, cosmetic and small glass products | ||
** Regional expansion in the USA, Mexico and China | ** Regional expansion in the USA, Mexico and China | ||
| Line 88: | Line 88: | ||
** Gerresheimer AG listed on MDAX | ** Gerresheimer AG listed on MDAX | ||
* 2009 - new R&D center opened in Peachtree City, Georgia, USA | * 2009 - new R&D center opened in Peachtree City, Georgia, USA | ||
* 2011 - acquisition of the | * 2011 - acquisition of the Brazilian pharmaceutical plastic packaging manufacturer Védat | ||
* 2012 - Medical Plastic Systems Division is further enlarged by the take-over of Münster-based item GmbH | * 2012 - Medical Plastic Systems Division is further enlarged by the take-over of Münster-based item GmbH | ||
** Majority shareholding in Neutral Glass & Allied Industries Pvt. Ltd | ** Majority shareholding in Neutral Glass & Allied Industries Pvt. Ltd | ||
| Line 121: | Line 121: | ||
===================================================================--> | ===================================================================--> | ||
{{PP Articles | {{PP Articles | ||
|2021|11|45|Cosmetic portfolio made from ocean-bound PET| | |||
|url1=http://www.gerresheimer.com|urlname1=Gerresheimer Website | |url1=http://www.gerresheimer.com|urlname1=Gerresheimer Website | ||
}} | }} | ||
{{Companies}} | {{Companies}} | ||